From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Federico Piñero; Ezequiel Mauro; Paola Casciato; Alejandro Forner;

Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma Miner Hu; Xiaojun Xia; Lichao Chen; Yunpeng Jin; Zhenhua Hu; Shudong Xia; Xudong Yao;

Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;